Literature DB >> 24093036

Cardiovascular risk factor modification among high-risk patients: Do pharmacists play a role?

Jeffrey Chow1, Tammy J Bungard.   

Abstract

Entities:  

Year:  2013        PMID： 24093036      PMCID： PMC3785190          DOI： 10.1177/1715163513499125

Source DB:  PubMed          Journal:  Can Pharm J (Ott)        ISSN： 1715-1635


× No keyword cloud information.
  12 in total

1.  Cardiovascular protection and blood pressure reduction: a meta-analysis.

Authors:  J A Staessen; J G Wang; L Thijs
Journal:  Lancet       Date:  2001-10-20       Impact factor: 79.321

2.  Secondary prevention of cardiovascular disease: a randomised trial of training in information management, evidence-based medicine, both or neither: the PIER trial.

Authors:  Julia Langham; Helen Tucker; David Sloan; Jane Pettifer; Simon Thom; Harry Hemingway
Journal:  Br J Gen Pract       Date:  2002-10       Impact factor: 5.386

3.  Prevalence of dyslipidemia in statin-treated patients in Canada: results of the DYSlipidemia International Study (DYSIS).

Authors:  Shaun G Goodman; Anatoly Langer; Natacha R Bastien; Ruth McPherson; Gordon A Francis; Jacques J Genest; Lawrence A Leiter
Journal:  Can J Cardiol       Date:  2010-11       Impact factor: 5.223

Review 4.  Blood pressure reduction and cardiovascular prevention: an update including the 2003-2004 secondary prevention trials.

Authors:  Jan A Staessen; Yan Li; Lutgarde Thijs; Ji-Guang Wang
Journal:  Hypertens Res       Date:  2005-05       Impact factor: 3.872

Review 5.  Primary prevention of cardiovascular diseases with statin therapy: a meta-analysis of randomized controlled trials.

Authors:  Paaladinesh Thavendiranathan; Akshay Bagai; M Alan Brookhart; Niteesh K Choudhry
Journal:  Arch Intern Med       Date:  2006-11-27

6.  Therapy modifications in response to poorly controlled hypertension, dyslipidemia, and diabetes mellitus.

Authors:  Nicolas Rodondi; Tiffany Peng; Andrew J Karter; Douglas C Bauer; Eric Vittinghoff; Simon Tang; Daniel Pettitt; Eve A Kerr; Joe V Selby
Journal:  Ann Intern Med       Date:  2006-04-04       Impact factor: 25.391

7.  Heart disease and stroke statistics--2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee.

Authors:  Donald Lloyd-Jones; Robert Adams; Mercedes Carnethon; Giovanni De Simone; T Bruce Ferguson; Katherine Flegal; Earl Ford; Karen Furie; Alan Go; Kurt Greenlund; Nancy Haase; Susan Hailpern; Michael Ho; Virginia Howard; Brett Kissela; Steven Kittner; Daniel Lackland; Lynda Lisabeth; Ariane Marelli; Mary McDermott; James Meigs; Dariush Mozaffarian; Graham Nichol; Christopher O'Donnell; Veronique Roger; Wayne Rosamond; Ralph Sacco; Paul Sorlie; Randall Stafford; Julia Steinberger; Thomas Thom; Sylvia Wasserthiel-Smoller; Nathan Wong; Judith Wylie-Rosett; Yuling Hong
Journal:  Circulation       Date:  2008-12-15       Impact factor: 29.690

8.  Hypertension treatment and control rates: chart review in an academic family medicine clinic.

Authors:  Sara J Houlihan; Scot H Simpson; Andrew J Cave; Nigel W Flook; Mary E Hurlburt; Chris J Lord; Linda L Smith; Harvey H Sternberg
Journal:  Can Fam Physician       Date:  2009-07       Impact factor: 3.275

9.  The impact of prevention on reducing the burden of cardiovascular disease.

Authors:  Richard Kahn; Rose Marie Robertson; Robert Smith; David Eddy
Journal:  Circulation       Date:  2008-07-07       Impact factor: 29.690

10.  Prevalence and treatment of dyslipidemia in Canadian primary care: a retrospective cohort analysis.

Authors:  Robert J Petrella; Elizabeth Merikle; Jared Jones
Journal:  Clin Ther       Date:  2007-04       Impact factor: 3.393
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.